Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.66 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.62 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL348655 | 0.90 | CHRM2 (0.78) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| SCHEMBL6205124 | 0.89 | CHRM2 (0.72) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| SCHEMBL284677 | 0.88 | CHRM2 (0.81) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| SCHEMBL3071526 | 0.88 | CHRM2 (0.81) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| SCHEMBL9777412 | 0.86 | CHRM2 (0.79) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL9702944 | 0.86 | CHRM2 (0.79) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3626828 | 0.86 | CHRM2 (0.79) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| SCHEMBL7004091 | 0.84 | HRH3 (0.79) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| SCHEMBL434742 | 0.83 | CHRM2 (0.68) | CHRM2HRH3LMNAALOX15ALDH1A1 | |
| SCHEMBL9188072 | 0.83 | CHRM2 (0.86) | CHRM2HRH3LMNAALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104704008-B | Water insoluble copolymers comprising pendant aryl epoxide groups | 罗门哈斯公司 | 2016-10-26 | — | — | CN | claimed |
| US-9321871-B2 | Water insoluble copolymer including pendant aryl epoxide groups | DOW GLOBAL TECHNOLOGIES LLC | 2016-04-26 | — | — | US | claimed |
| US-20150259456-A1 | WATER INSOLUBLE COPOLYMER INCLUDING PENDANT ARYL EPOXIDE GROUPS | ROHM AND HAAS CHEMICALS LLC | 2015-09-17 | — | — | US | claimed |
| CN-104704008-A | Water insoluble copolymers comprising pendant aryl epoxide groups | ROHM & HAAS | 2015-06-10 | — | — | CN | claimed |
| US-20230346769-A1 | USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS LEISHMANIA | UNIVERSIDAD DE GRANADA (ES) | 2023-11-02 | — | — | US | disclosed |
| US-20230346769-A1 | USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS LEISHMANIA | UNIVERSIDAD DE GRANADA (ES) | 2023-11-02 | — | — | US | disclosed |
| US-20230346769-A1 | USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS LEISHMANIA | UNIVERSIDAD DE GRANADA (ES) | 2023-11-02 | — | — | US | disclosed |
| EP-4180039-A1 | <SMALLCAPS/>? ? ?LEISHMANIA? ? ? ? ?USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS | Universidad de Granada (ES) | 2023-05-17 | — | — | EP | disclosed |
| EP-4180039-A1 | <SMALLCAPS/>? ? ?LEISHMANIA? ? ? ? ?USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS | Universidad de Granada (ES) | 2023-05-17 | — | — | EP | disclosed |
| WO-2022008784-A1 | USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS LEISHMANIA | UNIVERSIDAD DE GRANADA (ES) | 2022-01-13 | — | — | WO | disclosed |
| US-9321871-B2 | Water insoluble copolymer including pendant aryl epoxide groups | DOW GLOBAL TECHNOLOGIES LLC | 2016-04-26 | — | — | US | disclosed |
| US-9187588-B2 | Elution of metal ions from chelating resin using amino acid eluant | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-11-17 | — | — | US | disclosed |
| US-6187478-B1 | ENHANCED ACTIVE MATERIAL UTILIZATION EFFICIENCY AND UTILIZATION OF SULFURIC ACID ELECTROLYTE NECESSARY FOR DISCHARGE REACTION OF LEAD ACID BATTERY | ENSCI INC | 2001-02-13 | — | — | US | disclosed |
| US-6168886-B1 | CAPACITY MAINTENANCE | ENSCI INC | 2001-01-02 | — | — | US | disclosed |
| US-6132901-A | Battery element containing efficiency improving additives | ENSCI INC (US) | 2000-10-17 | — | — | US | disclosed |
| US-4098867-A | WATER-INSOLUBLE CHELATE EXCHANGE RESINS FROM AMINOPYRIDINES AND PROCESS FOR THE SELECTIVE EXTRACTION OF VALUABLE METALS USING THE SAME | THE DOW CHEMICAL COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
| US-4098867-A | WATER-INSOLUBLE CHELATE EXCHANGE RESINS FROM AMINOPYRIDINES AND PROCESS FOR THE SELECTIVE EXTRACTION OF VALUABLE METALS USING THE SAME | THE DOW CHEMICAL COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
| US-4031038-A | Water insoluble chelate exchange resins having a crosslinked polymer matrix and pendant thereto a plurality of methyleneaminopyridine groups | THE DOW CHEMICAL COMPANY (US) | 1977-06-21 | — | — | US | disclosed |
| US-4031038-A | Water insoluble chelate exchange resins having a crosslinked polymer matrix and pendant thereto a plurality of methyleneaminopyridine groups | THE DOW CHEMICAL COMPANY (US) | 1977-06-21 | — | — | US | disclosed |
| US-3998924-A | Recovery of non-ferrous metals from acidic liquors with a chelate exchange resin in presence of iron(III) | THE DOW CHEMICAL COMPANY (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346769-A1 | USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS LEISHMANIA | SRM, SMS, ARG2 | CHRM2 1038/4885HRH3 378/4885LMNA 1805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.